Table 1 Patients' characteristics
SEX | AGE (YEARS) | HCV GENOTYPE | SUBSTITUTION | RESPONSE | |
|---|---|---|---|---|---|
RF006 | M | 39 | 3a | Non-responder | |
RF007 | F | 28 | 3e | K210E ATP binding site | Non-responder |
RF009 | M | 51 | 3a | Non-responder | |
RF015 | M | 50 | 3a | Virological sustained responder | |
RF018 | M | 49 | 3a | Virological sustained responder | |
RF020 | M | 41 | 3e | W501R RNA binding site | Non-responder |
RF059 | F | 54 | 3a | F444S | Virological sustained responder |
RF060 | M | 48 | 3a | Non-responder | |
RF061 | M | 38 | 3e | Virological sustained responder | |
RF075 | F | 46 | 3a | Non-responder | |
RF080 | M | 52 | 3a | Virological sustained responder | |
RF081 | M | 58 | 3a | Virological sustained responder | |
RF082 | F | 57 | 3a | Non-responder | |
RF096 | M | 60 | 3a | Virological sustained responder | |
RF115 | M | 41 | 3a | Non-responder | |
RF145 | M | 51 | 3a | Non-responder |